摘要
目的探讨脾切除术后重症肺炎患者血小板减少的安全有效防治方法,为临床药师参与此类患者个体化药学服务提供借鉴。方法借助相关指南及文献,对脾切除术后重症肺炎患者引起血小板减少的因素分析及讨论,向临床医生提供药物治疗措施和建议。结果临床药师协助医生排查导致患者血小板降低的可能原因,并提出对于此类患者的药学监护要点。结论通过对脾切除术后重症肺炎患者血小板减少的因素分析,为临床药师对该类患者实施有效的药学服务提供参考。
Objective To explore safe and effective therapies for thrombocytopenia in patients with severe pneumonia after splenectomy and to provide reference for participation of clinical pharmacists in individualized pharmaceutical care for patients.Methods Based on related guidelines and literature,the causes of thrombocytopenia in patients with severe pneumonia after splenectomy were analyzed before were treatments were recommended to clinicians.Results The clinical pharmacist assisted the doctor in charge in finding out about the possible cause of the patient’s thrombocytopenia,and suggested the priority of pharmaceutical care.Conclusion Analysis of the possible causes of thrombocytopenia in patients with severe pneumonia after splenectomy can help clinical pharmacists to deliver effective pharmaceutical services for such patients.
作者
訾晨晨
张丹
孙丽丹
王礼玲
王慧
鲍蕾蕾
ZI Chen-chen;ZHANG Dan;SUN Li-dan;WANG Li-ling;WANG Hui;BAO Lei-lei(The Third Affiliated Hospital of Naval Medical University,Shanghai 200438,China;Changhai Hospital,Naval Medical University,Shanghai 200433,China)
出处
《解放军药学学报》
CAS
2022年第3期276-278,281,共4页
Pharmaceutical Journal of Chinese People's Liberation Army
关键词
脾切除术后重症肺炎
血小板减少
药学监护
severe pneumonia after splenectomy
thrombocytopenia
pharmaceutical care